| Primary |
| Hypertension |
23.7% |
| Product Used For Unknown Indication |
21.1% |
| Prinzmetal Angina |
18.4% |
| Drug Use For Unknown Indication |
5.3% |
| Tachycardia |
5.3% |
| Atrial Fibrillation |
2.6% |
| Cardiac Failure |
2.6% |
| Chest Pain |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Hypertensive Emergency |
2.6% |
| Insomnia |
2.6% |
| Myocardial Infarction |
2.6% |
| Prophylaxis |
2.6% |
| Sedation |
2.6% |
| Suicide Attempt |
2.6% |
|
| Shock |
17.6% |
| Agranulocytosis |
5.9% |
| Bradycardia |
5.9% |
| Memory Impairment |
5.9% |
| Myocardial Infarction |
5.9% |
| Nodal Rhythm |
5.9% |
| Overdose |
5.9% |
| Pallor |
5.9% |
| Restlessness |
5.9% |
| Self-medication |
5.9% |
| Skin Lesion |
5.9% |
| Tachycardia |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Toxicity To Various Agents |
5.9% |
| White Blood Cell Count Increased |
5.9% |
|
| Secondary |
| Hypertension |
37.7% |
| Drug Use For Unknown Indication |
16.3% |
| Product Used For Unknown Indication |
12.6% |
| Angina Pectoris |
3.3% |
| Aplasia Pure Red Cell |
2.5% |
| Cardiac Failure Congestive |
2.5% |
| Constipation |
2.5% |
| Myocardial Infarction |
2.5% |
| Prophylaxis |
2.5% |
| Anticoagulant Therapy |
2.1% |
| Antiplatelet Therapy |
2.1% |
| Anxiety |
2.1% |
| Gastritis |
2.1% |
| Cardiovascular Event Prophylaxis |
1.7% |
| Lipids Decreased |
1.7% |
| Cardiac Failure |
1.3% |
| Cerebral Infarction |
1.3% |
| Diabetes Mellitus |
1.3% |
| Hyperlipidaemia |
1.3% |
| Atrial Fibrillation |
0.8% |
|
| Syncope |
13.3% |
| Hepatitis Acute |
8.9% |
| Bradycardia |
6.7% |
| Liver Disorder |
6.7% |
| Phlebitis |
6.7% |
| Platelet Count Decreased |
6.7% |
| Suicide Attempt |
6.7% |
| Aspartate Aminotransferase Increased |
4.4% |
| Drug Eruption |
4.4% |
| Erythema Multiforme |
4.4% |
| Monoplegia |
4.4% |
| Renal Impairment |
4.4% |
| Skin Lesion |
4.4% |
| White Blood Cell Count Increased |
4.4% |
| Anaemia |
2.2% |
| Arrhythmia |
2.2% |
| Circulatory Collapse |
2.2% |
| Dyspepsia |
2.2% |
| Flank Pain |
2.2% |
| Hypoglycaemia |
2.2% |
|
| Concomitant |
| Hypertension |
24.8% |
| Product Used For Unknown Indication |
16.0% |
| Drug Use For Unknown Indication |
10.5% |
| Angina Pectoris |
7.5% |
| Prophylaxis |
5.0% |
| Rheumatoid Arthritis |
5.0% |
| Constipation |
3.7% |
| Gastritis |
3.3% |
| Insomnia |
3.3% |
| Multiple Myeloma |
2.9% |
| Gastric Ulcer |
2.3% |
| Pneumonia |
2.2% |
| Atrial Fibrillation |
1.9% |
| Ovarian Cancer Recurrent |
1.9% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Spinal Osteoarthritis |
1.7% |
| Renal Transplant |
1.6% |
| Arrhythmia |
1.5% |
| Cardiac Disorder |
1.5% |
| Hyperlipidaemia |
1.5% |
|
| Renal Impairment |
10.3% |
| Rhabdomyolysis |
8.9% |
| Pneumonia |
6.2% |
| Vomiting |
6.2% |
| Hepatic Function Abnormal |
5.5% |
| Hyponatraemia |
5.5% |
| Interstitial Lung Disease |
5.5% |
| Renal Failure |
5.5% |
| Septic Shock |
5.5% |
| Pneumonia Aspiration |
4.8% |
| Sudden Death |
4.8% |
| Pyrexia |
4.1% |
| Syncope |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Epilepsy |
3.4% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Tremor |
3.4% |
| Weight Increased |
3.4% |
| Agranulocytosis |
2.7% |
| Flank Pain |
2.7% |
|
| Interacting |
| Hypertension |
33.3% |
| Arteritis Obliterans |
11.1% |
| Cerebral Infarction |
11.1% |
| Diabetes Mellitus |
11.1% |
| Lipid Metabolism Disorder |
11.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.1% |
| Wound Infection |
11.1% |
|
| Ventricular Tachycardia |
100.0% |
|
